 |
|
|
| |
Associations Between Serum Bile-Acid Species With Liver Fibrosis and
Prognosis in Patients With Primary Sclerosing Cholangitis
|
| |
| |
EASL 2020 Aug 27-29
Reported by Jules Levin
Michael H. Trauner,1 Kris V. Kowdley,2 Atsushi Tanaka,3 Jun Xu,4 Ya Wang,4 Guang Chen,4 Andrew N. Billin,4 Chuhan Chung,4 Robert P. Myers,4 Zachary Goodman,5 Andrew J. Muir,6 Michael Manns,7 Douglas Thorburn,8 Cynthia Levy,9 Christopher L. Bowlus10
1Medical University of Vienna, Austria; 2Liver Institute Northwest, Seattle, Washington, USA; 3Teikyo University School of Medicine, Tokyo, Japan; 4Gilead Sciences, Inc., Foster City, California, USA; 5Inova Fairfax Hospital, Falls Church, Virginia, USA; 6Duke Clinical Research Institute, Durham, North Carolina, USA; 7Medizinische Hochschule Hannover, Germany; 8UCL Institute for Liver & Digestive Health, Royal Free Hospital, London, UK; 9University of Miami, Coral Gables, Florida USA; 10University of California, Davis, USA
References: 1. Chapman R, et al. Hepatology 2010;51:660-78; 2. Lindor KD, et al. Am J Gastroenterol 2015;110:646-59; 3. Serge JZ, et al. Hepatology Int 2017;11:132-40; 4. Trauner MH, et al. Hepatology 2019;70:788-801; 5. Chiang JY, et al. J Biol Chem 2000;275:10918-24; 6. Chiang JY, et al. J Lipid Res 2009;50:1955-66. Acknowledgments: We extend our thanks to the patients and their families. This study was funded by Gilead Sciences, Inc.
|
| |
|
|
|
|
|
